Related Experiment Video
Updated: Jun 8, 2026
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
[The experimental study of radioimmunoguided surgery for lung cancer.]
1Department of Thoracic Surgery , General Hospital of PLA , Beijing 100853 , P. R. China.
Background:
To determine the sensitivity , specificity and reliability of radioimmunoguided surgery in detecting the tumor micrometastases of the mice models bearing pulmonary adenocarcinoma.
Methods:
Radioimmunoguided surgery was performed on mice models bearing pulmonary adenocarcinoma with antihuman lung adenocarcinoma monoclonal antibody (LC-1) by biotin-avidin pretargeting technique.
Results:
The result of gamma-camera radioimmunoimaging and the data of radioactivity biodistribution provided by standard gamma well counts showed : as early as 2 hours after injection , radioactivity had accumulated in tumors of the biotinylated monoclonal antibodies pretargeting mice. The T/ NT ratios of the primary tumors and the metastases in the lung were significantly higher in the biotinylated monoclonal antibodies pretargeting mice than those without undergoing such treatment ( P < 0. 01) . Based on the application of GDP to identify the metastases in the lung ,the sensitivity , specificity and accuracy of RIGSwere 96 % , 98 % and 97 % respectively.
Conclusions:
Biotin-avidin pretargeting techniques could remarkably enhance the radio-active deposition on tumors of the biotinylated LC-1 pretargeting mice. The primary tumors and the micrometastases in the lung could be detected in vivo by GDP.
Insights
Radioimmunoguided surgery (RIGS) using biotin-avidin pretargeting effectively detects lung adenocarcinoma micrometastases in mice. This method significantly enhances radioactive deposition, improving tumor visualization and diagnostic accuracy.
Area of Science:
- Oncology
- Surgical Oncology
- Diagnostic Imaging
Context:
- Pulmonary adenocarcinoma poses a significant challenge due to micrometastatic spread.
- Early and accurate detection of micrometastases is crucial for effective treatment and improved patient outcomes.
- Current diagnostic methods may have limitations in identifying small, widespread tumor deposits.
Purpose:
- To evaluate the sensitivity, specificity, and reliability of radioimmunoguided surgery (RIGS) for detecting pulmonary adenocarcinoma micrometastases in a mouse model.
- To assess the efficacy of the biotin-avidin pretargeting technique in enhancing tumor-specific radio-antibody deposition.
- To determine the in vivo diagnostic capability of RIGS with gamma-probe detection (GDP) for primary tumors and lung metastases.
Summary:
- Radioimmunoguided surgery utilizing antihuman lung adenocarcinoma monoclonal antibody (LC-1) and biotin-avidin pretargeting was performed on mice models.
- Radioactivity accumulation in tumors was observed as early as 2 hours post-injection in pretargeted mice.
- The study demonstrated high sensitivity (96%), specificity (98%), and accuracy (97%) for RIGS in detecting lung metastases, with significantly higher tumor-to-non-tumor ratios compared to controls.
Impact:
- The biotin-avidin pretargeting technique significantly enhances radioactive deposition on tumors, improving diagnostic capabilities.
- RIGS, combined with GDP, enables effective in vivo detection of primary pulmonary adenocarcinoma tumors and lung micrometastases.
- This approach holds potential for improving the early detection and surgical management of lung cancer by identifying even small metastatic lesions.
